The purpose of this study was to retrospectively analyze the images of whole-body PSMA PET/CT or PET/MR followed by delayed limited pelvic PSMA PET/MR in patients diagnosed with or suspicion of prostate cancer, and to explore how to rationally use PET/CT and PET/MR in prostate diseases. The gene discussed is FOLH1; the disease is prostate cancer.